WO2006015183A3 - Pharmaceutical compositions for treating disorders of the skin - Google Patents

Pharmaceutical compositions for treating disorders of the skin Download PDF

Info

Publication number
WO2006015183A3
WO2006015183A3 PCT/US2005/026909 US2005026909W WO2006015183A3 WO 2006015183 A3 WO2006015183 A3 WO 2006015183A3 US 2005026909 W US2005026909 W US 2005026909W WO 2006015183 A3 WO2006015183 A3 WO 2006015183A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin
pharmaceutical compositions
treating disorders
decubitis
treating
Prior art date
Application number
PCT/US2005/026909
Other languages
French (fr)
Other versions
WO2006015183A2 (en
Inventor
Gosse B Bruinsma
Original Assignee
Axonyx Inc
Gosse B Bruinsma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axonyx Inc, Gosse B Bruinsma filed Critical Axonyx Inc
Publication of WO2006015183A2 publication Critical patent/WO2006015183A2/en
Publication of WO2006015183A3 publication Critical patent/WO2006015183A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Abstract

The invention relates to a method of treating a decubitis ulcer in a subject and a method of identifying a compound useful in the treatment of decubitis. In addition, active dressings, ointments and/or lotions having a means for improving healing of the decubitis ulcer are provided.
PCT/US2005/026909 2004-07-30 2005-07-29 Pharmaceutical compositions for treating disorders of the skin WO2006015183A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59241104P 2004-07-30 2004-07-30
US60/592,411 2004-07-30

Publications (2)

Publication Number Publication Date
WO2006015183A2 WO2006015183A2 (en) 2006-02-09
WO2006015183A3 true WO2006015183A3 (en) 2006-05-04

Family

ID=35787851

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/026909 WO2006015183A2 (en) 2004-07-30 2005-07-29 Pharmaceutical compositions for treating disorders of the skin

Country Status (1)

Country Link
WO (1) WO2006015183A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20120062A1 (en) * 2012-03-21 2013-09-22 Minerva Patents S A COMPONENTS FOR THE TREATMENT OF DISEASES RELATED TO ISCHEMIA-REPERFUSION.
ITFI20130304A1 (en) * 2013-12-24 2015-06-25 Univ Firenze BICYCLIC PEPTIDOMIMETICS FOR USE IN THE TREATMENT OF FUNGAL INFECTIONS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951968A (en) * 1973-10-03 1976-04-20 Delalande S.A. (2-6-Oxymethylene) morpholino (4,3a) benzimidazoles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951968A (en) * 1973-10-03 1976-04-20 Delalande S.A. (2-6-Oxymethylene) morpholino (4,3a) benzimidazoles

Also Published As

Publication number Publication date
WO2006015183A2 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
WO2006040688A3 (en) Inhibitors of acetylcholinesterase for treating skin diseases
WO2005039504A3 (en) Compounds and methods for treating toll-like receptor 2-related diseases and conditions
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
TWI345979B (en) Topical pharmaceutical compositions for the treatment of dermatitis
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
WO2006015035A8 (en) Useful compounds for hpv infection
WO2006120682A3 (en) Compositions and methods for treating hyperproliferative epidermal diseases
WO2006003492A3 (en) Compositions and methods for treating pathological infections
BRPI0506970A (en) alpha-aminoamide derivatives useful in treating lower urinary tract disorders
WO2007074406A3 (en) Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative
WO2006034491A3 (en) Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes
WO2007075695A3 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
GB2445674B (en) Compositions for the topical treatment of eczema, psoriasis and the like
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
BRPI0514600A (en) methods for manufacturing a compound, for purifying a compound, for treating an individual having a neoplastic condition, having squamous cell carcinoma, and having basal cell carcinoma, for reducing or preventing the occurrence of a neoplastic condition in an individual, and for the reduction of serum triglycerides in an individual, compound, and, pharmaceutical composition
AU2003301761A1 (en) Method for treating wounds to promote healing
WO2006089664A3 (en) Heterocyclylamide-substituted imidazoles
AU2003229284A1 (en) Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
WO2005112923A3 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
WO2003039453A3 (en) Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
WO2007130509A3 (en) Pyrroloquinoline quinones and use thereof
ZA200609220B (en) Method of treating dry eye disorders and uveitis
WO2004087700A8 (en) Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase